Abstract
The ability of human immunodeficiency virus (HIV)- and equine infectious anaemia virus (EIAV)-based vectors to transduce cell lines from a range of species was compared. Both vectors carried the vesicular stomatitis virus G (VSV-G) envelope protein and encoded an enhanced green fluorescent protein (eGFP) gene driven by a human cytomegalovirus (CMV) early promoter. Immunostaining for viral core proteins and VSV-G was used to demonstrate that the HIV and EIAV vector preparations contained similar numbers of virus particles. Various cell lines were transduced with these vectors and the transduction efficiency was estimated by measuring eGFP expression. Efficient transduction by both vectors was observed in human, hamster, pig, horse, cat and dog cell lines, although EIAV vector was about 10-fold less efficient in human, hamster and pig cells normalised to the total number of viral particles. This could be partly explained by the lower RNA genome levels per particle for EIAV as measured by real-time RT-PCR. Rodent cells appeared to be transduced inefficiently with both vectors, but when the CMV promoter was substituted with the EF1α promoter in the HIV vectors, the expression level increased leading to an increase in the measurable level of transduction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akkina RK et al. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G J Virol 1996 70: 2581–2585
Follenzi A et al. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences Nat Genet 2000 25: 217–222
Naldini L et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 1996 272: 263–267
Kotsopoulou EA et al. Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene J Virol 2000 74: 4839–4852
Kim VN, Mitrophanous K, Kingsman SM, Kingsman AJ . Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1 J Virol 1998 72: 811–816
Johnston JC et al. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors J Virol 1999 73: 4991–5000
Wang G et al. Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect J Clin Invest 1999 104: 55–62
Poeschla EM, Wong-Staal F, Looney DJ . Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors Nat Med 1998 4: 354–357
Curran MA, Kaiser SM, Achacoso PL, Nolan GP . Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors Mol Ther 2000 1: 31–38
Mitrophanous K et al. Stable gene transfer to the nervous system using a non-primate lentiviral vector Gene Therapy 1999 6: 1808–1818
Olsen JC . Gene transfer vectors derived from equine infectious anemia virus Gene Therapy 1998 5: 1481–1487
Mazarakis ND et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery Hum Mol Genet 2001 10: 2109–2121
Taube R et al. Interactions between equine cyclin T1, Tat and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1 J Virol 2000 74: 892–898
Hofmann W et al. Species-specific, postentry barriers to primate immunodeficiency virus infection J Virol 1999 73: 10020–10028
Zufferey R et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo Nat Biotechnol 1997 15: 871–875
Pizzato M, Marlow SA, Blair ED, Takeuchi Y . Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction J Virol 1999 73: 8599–8611
Abe A, Chen ST, Miyanohara A, Friedmann T . In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein J Virol 1998 72: 6356–6361
Sharma S, Miyanohara A, Friedmann T . Separable mechanisms of attachment and cell uptake during retrovirus infection J Virol 2000 74: 10790–10795
Rohll JB et al. The design, production, safety, evaluation and clinical applications of non-primate lentiviral vectors Meth Enzymol 2002 346: 466–500
Porter CD et al. Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo J Virol 1998 72: 4832–4840
Neil S, Martin F, Ikeda Y, Collins M . Post-entry restriction to human immunodeficiency virus-based vector transduction in human monocytes J Virol 2001 75: 5448–5456
Acknowledgements
This work was supported by United Kingdom Medical Research Council and Cancer Research Campaign.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ikeda, Y., Collins, M., Radcliffe, P. et al. Gene transduction efficiency in cells of different species by HIV and EIAV vectors. Gene Ther 9, 932–938 (2002). https://doi.org/10.1038/sj.gt.3301708
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301708
Keywords
This article is cited by
-
Enzyme-free targeted DNA demethylation using CRISPR–dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression
Nature Protocols (2022)
-
A novel intranuclear RNA vector system for long-term stem cell modification
Gene Therapy (2016)
-
Production of lentiviral vectors
Molecular Therapy - Methods & Clinical Development (2016)
-
The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation
The EMBO Journal (2013)
-
The conserved UL24 family of human alpha, beta and gamma herpesviruses induces cell cycle arrest and inactivation of the cyclinB/cdc2 complex
Archives of Virology (2009)